Trenzyme GmbH
EMEA
Konstanz
,
Germany
Established
FOUNDED
2000
HEADCOUNT
2-20
FUNDING
Privately held
Keywords:
CRO, bacteria, yeast, mammalian_cells
BUSINESS
Trenzyme is a privately owned, ISO 9001:2015 certified CRO providing customized services in cell line development, iPSC differentiation, and recombinant protein production across multiple expression platforms (E. coli, yeast, mammalian, insect/baculovirus). The company celebrated its 25th anniversary in 2025. No venture funding; self-sustaining on service revenue. Clients span academia, small biotechs, and large pharmaceutical companies internationally. Collaboration partnerships include Oxford Expression Technologies (baculovirus/BacMam systems), 2bind (biophysical analytics), BioGenes (antibody development), and Biofidus (bioanalytics). The company also offers catalog recombinant proteins via an online webshop.
BIOTECH INVOLVEMENT
Core enabling; CRO using mammalian cell culture and microbial recombinant expression as key biotech tools for R&D projects.
TECHNOLOGY PLATFORM
cell line development; recombinant protein expression; iPSC differentiation
PRIMARY PRODUCTS
Custom stable cell lines; GMP-compliant research cell banks; recombinant proteins